Financhill
Back

Seres Therapeutics Vs. PDS Biotechnology Industry Stock Comparison

Sell
25

MCRB
Seres Therapeutics

Last Price:
0.58
Seasonality Move:
-13.92%
Sell
38

PDSB
PDS Biotechnology

Last Price:
2.26
Seasonality Move:
1.73%
Sell
25
Seres Therapeutics (MCRB) is a Sell

Is Seres Therapeutics a Buy, Sell or Hold?

  • The current Seres Therapeutics [MCRB] share price is $0.59. The Score for MCRB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • MCRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
PDS Biotechnology (PDSB) is a Sell

Is PDS Biotechnology a Buy, Sell or Hold?

  • The current PDS Biotechnology [PDSB] share price is $2.76. The Score for PDSB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • PDSB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MCRB Stock Price Chart

What is Seres Therapeutics's stock price today?

  • The Seres Therapeutics share price today is $0.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.

PDSB Stock Price Chart

What is PDS Biotechnology's stock price today?

  • The PDS Biotechnology share price today is $2.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDSB is experiencing selling pressure, which indicates risk of future bearish movement.

MCRB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 27.93 Sell
Chaikin Money Flow: -5154121 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.7 - 0.82) Sell
Bollinger Bands (100): (0.74 - 1.12) Sell

PDSB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 31.7 Sell
Chaikin Money Flow: -514080 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 3.34) Sell
Bollinger Bands (100): (2.98 - 3.66) Sell

MCRB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.72 Sell
20-day SMA: 0.76 Sell
50-day SMA: 0.86 Sell
200-day SMA: 0.92 Sell
8-day EMA: 0.7 Sell
20-day EMA: 0.75 Sell
50-day EMA: 0.82 Sell
200-day EMA: 1.16 Sell

PDSB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.16 Sell
20-day SMA: 3.18 Sell
50-day SMA: 3.25 Sell
200-day SMA: 3.7 Sell
8-day EMA: 3.09 Sell
20-day EMA: 3.18 Sell
50-day EMA: 3.25 Sell
200-day EMA: 3.72 Sell

Seres Therapeutics Earnings Growth & MCRB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.18 per share.

PDS Biotechnology Earnings Growth & PDSB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.24 per share.

Seres Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PDS Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):